Oncortarget Purposes to put an end to Cancer by publishing important information

Oncortarget is an American based peer-reviewed access journal which contains medical articles on oncology. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Oncology, therefore, deals with functions of the cells common in aging and cancer. Oncortarget publishes subsections on topics such as Aging, Immunology, Microbiology among others and the access to this information is free Research of cancerous tumors is been done to get information on how to manage and treat the malignant cells during the early stages. Check the journal at SCImago Journal & Country Rank.

The oncortarget journal is published once per week as this information is of importance as most people are succumbing to cancer. The information published on Oncortarget is on the pervasiveness of the disease and its primary causes, the treatments available and future possible ways to control and possibly eliminate it. The scientists who publish this journal are those who have vast knowledge and are highly skilled in the different roles they play.

The oncortarget mission is to make the scientific findings available to a large number of people at the shortest time possible; bringing together diverse specialists and linking different sectors of medical research and researchers along with their various discoveries. To be able to serve all who needs the information, Oncortarget makes sure that two free issues are available to the public on Tuesdays and Fridays. Follow Oncotarget journal on Twitter.

To further increase the reach and influence of scientific information, the papers which are accepted are later published in PubMed. Recently, Oncortarget published research conducted involving the Alzheimer’s disease and diabetes. The research findings were that those people with Alzheimer’s disease have a higher risk of diagnosis with type 2 diabetes in future.

On 19th September this year, Oncortarget reassured its readers that its publications would continue to be available on PubMed. In partnership with National Library of Medicine, Oncortarget has become the first scientific journal to submit its issues to PubMed days after it publishes the information online. Oncortarget aims at eliminating this 21 century ‘killer’ and targets to see a life without disease.

Read: https://www.eurekalert.org/pub_releases/2017-10/cg-e-s101817.php